Principal Investigator
Hadar Lev-Tov
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20231330
Clinical Trial Summary
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other